Panel Discussion: Future Directions of Diagnostic Technologies in Wet AMD & DME

Time: 11:15 am
day: Day Two


  • Discussion around the latest diagnostic technologies which can measure eye disease progression, stratify clinical trial patient populations, and be utilized to demonstrate candidate drug efficacy and safety
  • A focus on the role of artificial intelligence algorithms and how they can be used to aid diagnosis and monitor progression of patients with wet AMD and DME